Loading...
Nyxoah S.A.
NYXH•NASDAQ
Healthcare
Medical - Instruments & Supplies
$7.22
$-0.57(-7.32%)
Nyxoah S.A. (NYXH) Company Profile & Overview
Explore Nyxoah S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Nyxoah S.A. (NYXH) Company Profile & Overview
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
SectorHealthcare
IndustryMedical - Instruments & Supplies
CEOOlivier Taelman
Contact Information
Company Facts
183 Employees
IPO DateApr 28, 2021
CountryBE
Actively Trading